4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow crofelemer: new trials by email Literature Review of crofelemer trials Research Report on crofelemer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib Neratinib, Trastuzumab, Loperamide - HER2-positive Breast Cancer, Breast Adenocarcinoma | Phase 2 | Completed | University of California, San Francisco | 11 | 2018-10-09 | 2025-06-26 |
| Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Crofelemer - Breast Cancer | Phase 2 | Completed | Sandra Swain | 53 | 2017-01-31 | 2022-10-24 |
| Diarrhea Predominant Irritable Bowel Syndrome in Females crofelemer - Irritable Bowel Syndrome | Phase 2 | Completed | Bausch Health Americas, Inc. | 240 | 2006-10-01 | 2019-11-25 |
| A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome crofelemer - Irritable Bowel Syndrome, Colonic Diseases | Phase 2 | Completed | Bausch Health Americas, Inc. | 245 | 2004-12-01 | 2019-11-25 |
Breast Neoplasms (2) · Irritable Bowel Syndrome (2) · Abdominal Pain (1) · Colonic Diseases (1) · Diarrhea (1) · Gastrointestinal Diseases (1)
Bausch Health Americas, Inc. (2) · Sandra Swain (1) · University of California, San Francisco (1)
United States (4)
Jo Chien, MD (1)